DSpace logo

Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 51-60 of 373 (Search time: 0.004 seconds).
Item hits:
Issue DateTitleAuthor(s)
2015-05Type 4 phosphodiesterase enzyme inhibitor, rolipram rescues behavioral deficits in olfactory bulbectomy models of depression: Involvement of hypothalamic–pituitary–adrenal axis, cAMP signaling aspects and antioxidant defense systemMahesh, R.
2015Insignificant in vitro falcipain-2 inhibitory activity of novel 2-(4-(substituted benzoyl) piperazine-1-yl)-N-phenylacetamide derivativesMahesh, R.
2010Demographic study on disease prevalence and their treatment pattern in a local hospital of a semi-urban communityMahesh, R.
2013Anxiolytic Effect of a Novel 5-HT3 Receptor Antagonist (4-Phenylpiperazin-1-yl)(Quinoxalin-2-yl) Methanone (4a) in a Battery of Behavioral Models for Anxiety in MiceMahesh, R.
2015-01Piperazine Analogs of Naphthyridine-3-carboxamides and Indole-2-carboxamides: Novel 5-HT3 Receptor Antagonists with Antidepressant-Like ActivityMahesh, R.
2010-02Review: The auspicious role of the 5-HT3 receptor in depression: a probable neuronal target?Mahesh, R.
2016-014i (N-(3-Chloro-2-methylphenyl) quinoxalin-2-carboxamide), a novel 5-HT3 receptor antagonist alleviates depressive behavior evoked in streptozotocin-induced diabetic mice: Role of oxidative stressMahesh, R.
2013Neuro-pharmacological evaluation of structurally novel 5-hydroxytryptamine type 3 receptor antagonist, N-n-propyl-3-ethoxyquinoxaline-2-carboxamide (6n) for its anxiolytic potentialMahesh, R.
2013An unusual case of xylophagia (paper-eating)Mahesh, R.
2018-05Peptides, Peptidomimetics, and Carbohydrate–Peptide Conjugates as Amyloidogenic Aggregation Inhibitors for Alzheimer’s DiseaseJadhav, Hemant R.